6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	APi Group Reports First Quarter 2026 Financial Results
Just now	Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
Just now	VSE Corporation Announces May 2026 Investor Conference Schedule
Just now	Thryv Grows SaaS Revenue in First Quarter 2026, Exceeds Total Company Revenue and EBITDA Guidance
1m ago	Organon Reports Results for the First Quarter Ended March 31, 2026

About

Rallybio Corp (NASDAQ:RLYB) — investor relations, events, news, and company updates on 6ix.

Latest News

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement

Rallybio Announces Reverse Stock Split of Common Stock

Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

Financials

Revenue

$858 K

Market Cap

$44.59 M

EPS

-1.59

Community Chat

Ask AI